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Abstract The Escherichia coli metB gene has been PCR-
extracted from genomic DNA and placed under the control of a 
tac and a T7 promoter in plasmids pCYBl and pET22b(+), 
respectively, to produce overexpressing bacterial strains for the 
gene product, cystathionine γ-synthase. Efficient purification 
procedures have been developed for a C-terminally intein-tagged 
version and the wild-type target protein, yielding the product in a 
quantity and homogeneity amenable to high-resolution single-
crystal X-ray analysis. Crystals have been obtained in space 
group PI with unit cell constants a = 82.2 A, b = 84.2 A, 
c= 116.2 Á, a =107.0°, β = 96.3°, γ= 108.0°, suggesting eight 
monomers per asymmetric unit (VM = 2.23 A3/Da). Crystals 
diffract to beyond 2.6 A resolution and a data set complete to 2.8 
A resolution has been collected using a rotating anode X-ray 
source. A cryogenic buffer system has been developed to allow 
synchrotron data collection. Patterson self rotation searches 
reveal the presence of two independent tetramers with local 222 
symmetry in an asymmetric unit. The crystallographic results 
corroborate and extend previous solution studies regarding the 
quaternary organization of the enzyme. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
De novo synthesis of methionine is carried out only by 
microorganisms and higher plants, suggesting that the en-
zymes involved are attractive targets for antibiotics and her-
bicide design. High resolution three-dimensional structures of 
the biological catalysts will prove invaluable in the quest for 
such agents. Cystathionine γ-synthase (CGS; EC 4.2.99.9; 386 
residues, 40 kDa) catalyzes the committing step in methionine 
biosynthesis, which is the formation of L-cystathionine from 
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Abbreviations: BSA, bovine serum albumin; CBL, cystathionine ß-
lyase; (e)CGS, cystathionine γ-synthase (E. coli); OTT, 1,4-dithio-
threitol; EDTA, ethylenediaminetetraacetic acid; HEPES, 7V-2-hy-
droxyethylpiperazine-/V'-2-ethane sulfonic acid; IPTG, isopropyl-ß-D-
thiogalactopyranoside; LB broth, Luria-Bertani broth; LB-Ampl00, 
LB broth containing 100 μg/ml ampicillin; LDH, lactate dehydrogen-
ase; MES, 2-(Ar-morpholino)-ethanesulfonic acid; MPD, 2-methyl-2,4-
pentanediol; NAD(H), nicotinamide adenine dinucleotide, oxidized 
(reduced) form; OSHS, O-succinyl-L-homoserine; PAGE, polyacryl-
amide gel electrophoresis; PCR, polymerase chain reaction; PEG, 
polyethylene glycol; PLP, pyridoxal 5'-phosphate; SDS, sodium 
dodecylsulfate; Tris, tris-(hydroxymethyl)-aminomethane; VM, Mat-
thews coefficient (crystal volume per protein mass; A3/Da) 
O-succinyl-L-homoserine (OSHS) and L-cysteine in a pyridox-
al 5'-phosphate (PLP) dependent γ-replacement reaction. 
eCGS is the product of the metB gene of Escherichia coli 
and belongs to the γ-family of PLP dependent enzymes [1]. 
It exhibits 30% sequence identity and 36% overall homology 
with E. coli cystathionine ß-lyase (eCBL) [2], which catalyzes 
the subsequent step in the methionine pathway, the ß-cleavage 
of L-cystathionine to homocysteine, pyruvate, and ammonia. 
This similarity indicates that CGS and CBL could have 
evolved from a common ancestor [2] and it is, not surpris-
ingly, paralleled by a number of common structural and bio-
chemical characteristics: both enzymes exert their functions in 
vivo as homo-tetramers with one PLP cofactor per monomer 
[3], which is bound via a Schiff base linkage to the ε-amino 
group of an active site lysine (K210 in eCBL, K198 in eCGS); 
CGS and CBL copurify in several systems [2,4]; and CGS can 
perform CBL-like ß-eliminations, albeit with much reduced 
efficiency [5]. Therefore the overall tertiary structure and 
even the active site architecture of CGS should be closely 
related to that of CBL, whose X-ray structure has recently 
been solved and refined to 1.83 A resolution [6]. 
Besides the above and the physiological reactions, CGS 
catalyzes in the absence of L-cysteine a γ-elimination from 
OSHS to succinate, oc-ketobutyrate, and ammonia [3]. More-
over, it accomplishes ß-replacement and a- or ß-proton ex-
change reactions with appropriate substrates [3,7,8]. The ace-
tylenic amino acid propargylglycine (2-amino-4-pentynoic 
acid) is a potent inactivator of plant and bacterial CGS [9-
12] and can thus be regarded as a lead for the development of 
new inhibitors. 
In this communication we present the design of eCGS over-
expressing strains of E. coli and efficient purification protocols 
which yield over 80 mg of pure eCGS per liter of cell culture. 
Furthermore, the crystallization and diffraction data collec-
tion as well as the revealing results from Patterson self rota-
tion analyses are described. 
2. Materials and methods 
2.1. Cloning and construction of expression strains 
The metB gene [13] was amplified via PCR [14,15] with E. coli 
genomic DNA as the template. 5'-Overhangs introduced NdellSapl 
(construct 1) and Ndel/BamHI (construct 2) restriction sites into the 
forward/reverse primers (MWG-Biotech, Ebersberg, Germany; for-
ward primer-1: 5'-GGA ATT CAT ATG ACG CGT AAA CAG 
GCC ACC ATC G-V; reverse primer-1: 5'-AAT CAC GCT CTT 
CCG CAC CCC TTG TTT GCA GCC CGG-V; forward primer-2: 
5'-GCC GAA TTC CAT ATG ACG CGT AAA CAG GCC ACC 
ATC-V; reverse primer-2: 5'-CGA CGG ATC CTA TTA CCC 
CTT GTT TGC AGC CCG GAA GC-3; restriction sites underlined, 
eCGS coding and template sequences in italics). The PCR products 
and vectors (construct 1: pCYBl, New England Biolabs, Beverly, 
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MA; construct 2: pET22b(+), Stratagene, La Jolla, CA) were digested 
with the appropriate restriction enzymes (New England Biolabs), li-
gated with T4 DNA ligase (New England Biolabs), and used for the 
electroporation (Gene Pulser, Bio-Rad, Hercules, CA) of E. coli strain 
XLl-Blue (Stratagene [16]). During cloning, all enzymatic steps were 
followed by heat inactivation of the enzymes and/or spin column 
purification of the desired DNA fragments (QIAquick, Qiagen, Chats-
worth, CA). Individual colonies, selected on ampicillin (100 μ§/ηι1) 
agar plates, were the source of plasmid preparations (Qiagen) for 
sequencing of the insert (Cycle Sequencing Ready Reaction Kit, Per-
kin Elmer, Foster City, CA) and transformation of E. coli strains 
DH5a or BL21(DE3) for the pCYBl and the pET22b(+) constructs, 
respectively. 
2.2. Expression and purification of intein-tagged eCGS (preparation 1) 
Individual colonies of the transformed E. coli strain DH5a (pCYBl 
construct) were raised to inoculate 5 1 of selective LB broth (100 μg/ml 
ampicillin; LB-Ampl00). After growing at 37°C to an OD595 of 0.6-
0.8, the cultures were induced by addition of isopropyl-ß-D-thiogalac-
topyranoside (IPTG) to a final concentration of 1 mM and allowed to 
grow for another 8 h. The cells were harvested by centrifugation 
(4000 Xg), resuspended in 10 ml buffer A (100 mM Tris-HCl, 
pH7.8, 10 μΜ PLP, 2 mM EDTA) per liter culture, and stored at 
—70°C. All subsequent procedures were carried out at 4°C or with the 
protein on ice. Chromatographie steps were conducted with self 
packed columns, peristaltic pumps, and gravity operated gradient 
mixers on Pharmacia Biotech (Uppsala, Sweden) UV detectors and 
fraction collectors. 
The cell suspension was sonicated on ice (Branson Sonifier, Dan-
bury, CT; macrotip, 100% output, 50% interval, 2X4 min) and the 
lysate cleared by ultracentrifugation (3 h, 50000 rpm, 55.2 Ti, Beck-
man Instruments, Palo Alto, CA). A 40 ml chitin column (New Eng-
land Biolabs) was equilibrated, loaded, and washed as suggested by 
the manufacturer, except for the omission of detergents in the buffers, 
in order not to compromise the structural integrity and homogeneity 
of the tagged eCGS. Cleavage of the eCGS from the column bound 
tag and elution was achieved with a 30 mM DTT wash. The effiux was 
fractionated and checked on 12% polyacrylamide SDS gels for purity. 
Peak fractions were pooled and adjusted to 1 M (NH4)2S04 with a 
saturated, pH 7.5 buffered (NH4)2S04 solution. The protein was 
loaded onto a 75 ml phenyl Sepharose HP column (Pharmacia Bio-
tech) and developed in a 500 ml gradient to 0 M (NH4)2S04. Frac-
tions were again checked on gels, the eCGS peak pooled, concentrated 
and buffer exchanged to 10 mM Tris-HCl, pH 7.8, 10 μΜ PLP via 
Centriprep-10 concentrators (Amicon, Beverly, MA), and shock fro-
zen in liquid nitrogen for storage at —70°C. 
2.3. Expression and purification of wild-type eCGS (preparation 2) 
In the case of the pET construct, the crude BL21(DE3) transfor-
mation mixture was used to inoculate a 50 ml LB-Ampl00 culture, 
which was grown to log phase and aliquoted into glycerol stocks [17]. 
The glycerol stocks served to inoculate 6 1 of LB-Ampl00 which were 
subsequently grown, induced, harvested, stored, and lysed as above. 
All subsequent steps were performed at 4°C or with the protein on ice. 
The cleared lysate was loaded onto a 500 ml DEAE Sepharose FF 
column (Pharmacia Biotech), equilibrated with buffer A, and eluted 
with a linear gradient of 0-0.5 M (NH4)2S04 in buffer A. eCGS peak 
fractions were identified by low OD2go/OD426 absorbance ratios (DU 
7500 spectrophotometer, Beckman Instruments) and conservatively 
pooled after checking their purity and molecular weight with 12% 
SDS PAGE. Pooled fractions were adjusted to 1 M (NH4)2S04 as 
above, chromatographed on a 75 ml phenyl Sepharose HP column 
(Pharmacia Biotech) equilibrated with buffer A plus 1 M (NH4)2S04, 
and eluted with a linear gradient of 1-0 M (NH4)2S04 in buffer A. 
The eCGS was identified on gels as before, concentrated in Centri-
prep-10 concentrators (Amicon), and further purified on a size exclu-
sion column (Sephacryl S200 HR, Pharmacia Biotech) in 100 mM 
Tris-HCl, pH 7.8, 10 μΜ PLP. The final pool was adjusted to 60% 
(NH4)2S04 and the eCGS precipitate was stored at 4°C without ac-
tivity loss throughout several months. 
2.4. Activity test 
eCGS activity was checked by the method of Kaplan and Flavin 
[18]. In a coupled assay, α-ketobutyrate, one product of the CGS 
catalyzed elimination reaction from OSHS, was reduced by lactate 
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dehydrogenase (LDH) and NADH in a 1 ml solution (100 mM 
Tris-HCl, pH 7.8, 10 μΜ PLP, 0.3 mM NADH, 1.25 mM OSHS, 
0.2 mg LDH from beef heart). Concomitant oxidation of NADH 
was spectroscopically monitored at 340 nm. eCGS concentrations 
were measured by a micro-BCA assay (Bio-Rad) against a BSA stand-
ard curve. 
2.5. Crystallization and data collection 
For crystallization trials eCGS was either thawed on ice (prepara-
tion 1) or its (NH4)2S04 pellet (preparation 2) harvested by centrifu-
gation (25 000 rpm, 20 min, JA-25.50, Beckman Instruments), resus-
pended in buffer A, and extensively dialyzed against 10 mM Tris-HCl, 
pH 7.8, 10 μΜ PLP. The protein concentration was adjusted to 15 
mg/ml to search for crystallization conditions at room temperature 
and 4°C with a 96 condition sparse matrix screen. For both eCGS 
preparations the most promising crystals appeared at room temper-
ature by vapor equilibration of sitting drops against 100 mM HEPES-
NaOH, pH 7.0, 20% (w/v) PEG-4000, 10% (v/v) 2-propanol within 
several weeks. The preparation 1 crystals were improved by screening 
of additives. While additives were of no use for preparation 2 eCGS, 
these crystals were optimized via pH PEG-4000 grid screens. Data 
were collected at 113 K on a MAR Research (Hamburg, Germany) 
image plate detector equipped with a Rigaku (Tokyo, Japan) RU 200 
rotating anode, producing graphite monochromated CuKa radiation 
(λ= 1.5418 A) at 50 kV/100 mA, and a liquid nitrogen cryosystem 
(KGV, Karlsruhe, Germany). The apparent focal spot size was 0.4 
mm X 0.4 mm. A single preparation 2 specimen sufficed to collect a 
180° φ scan with a 1.0° frame width and 1800 s exposure time per 
frame. The data were processed with the program packages 
MOSFLM [19] and CCP4 [20] and self rotation functions were calcu-
lated with the program GLRF [21]. 
3. Results and discussion 
3.1. Conventional and affinity tagged purification 
eCGS could be expressed without complications to high 
levels in E. coli both with a C-terminal affinity tag (self cleav-
able intein domain plus chitin binding domain) and as the 
wild type protein under the control of a tac or a T7 promoter , 
respectively. The recently introduced intein/affinity tag (Im-
pact I, New England Biolabs) represents a potential one-
step purification tool for recombinant proteins [22]. The 
tagged version released untagged eCGS upon D T T induced 
Fig. 1. 12% reducing SDS PAGE showing the products of the two 
eCGS preparations. Lane 1: eCGS preparation 2. Lane 2: eCGS 
preparation 1. Lane 3: Molecular weight markers (Sigma, Deisenho-
fen, Germany); low range marker, 66 kDa, BSA; 45 kDa, ovalbu-
min; 36 kDa, glyceraldehyde 3-phosphate dehydrogenase (rabbit 
muscle); 29 kDa, carbonic anhydrase (bovine erythrocytes); 24 
kDa, trypsinogen (bovine pancreas); 20 kDa, trypsin inhibitor (soy-
bean); 14.2 kDa, α-lactalbumin (bovine milk). 
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C-terminus. The 6 1 culture yielded about 30 mg of target 
protein. 
In order to avoid the apparent heterogeneity, eCGS was 
purified by conventional means from a T7 controlled expres-
sion system. The three-column procedure could be conven-
iently completed within 3 days and the eCGS product ad-
vanced as a single band of the expected molecular weight 
on SDS gels (Fig. 1). Over 500 mg of pure, crystallizable 
protein with an OD280/OD426 ratio of 3.3 has been prepared 
from 6 1 of cell culture with enrichment factors comparable to 
previous reports [23]. 
Both eCGS preparations exhibited similar specific activities 
when tested in a continuous coupled assay [18], further sug-
gesting that the double bands of preparation 1 constitute the 
same enzyme. Both products were extremely stable and did 
not show any significant activity loss when stored in various 
environments at room temperature, 4°C, or deep frozen. 
Fig. 2. Crystals of eCGS (preparation 2). Crystallization setup as 
described in the text. Note the influence of the pH. The two photo-
graphs are on the same scale, a: 100 mM MES/Tris, pH 7.5, 18% 
(w/v) PEG-4000, 10% (v/v) 2-propanol. b : 100 mM MES/Tris, pH 
7.2, 18% (w/v) PEG-4000, 10% (v/v) 2-propanol. 
on-column cleavage between the last residue of eCGS and the 
first residue of the intein/chitin binding portion. However, 
despite extensive washing steps, the preparation was not 
pure enough to be used in crystallization trials after the affin-
ity column, necessitating a subsequent hydrophobic interac-
tion chromatography step. The purity could probably be im-
proved by incorporating detergents in the washing buffers. On 
SDS gels the product presented itself as a double band with a 
major (about 2/3) component running at the expected molec-
ular weight (40 kDa), and a minor component with an appar-
ent molecular weight of ~ 4 5 kDa (Fig. 1). The two bands 
comigrated in all attempted Chromatographie procedures (chi-
tin beads, phenyl Sepharose HP, Sephacryl S200 HR) and did 
not disappear upon prolonged boiling before loading of the 
gels. The excellent OD280/OD426 ratio (3.5) of the preparation 
suggests that both components are eCGS, which might be 
inseparable under native conditions due to the formation of 
hetero-tetramers. N-terminal sequencing did not detect any 
heterogeneity leaving the possibility for extra residues on the 
3.2. Crystallization, data collection, and self rotation 
Both eCGS preparations yielded crystals under the same 
conditions in the preliminary trials, using sitting drop vapor 
diffusion with 4.5 μΐ drops (3 μΐ protein at 15 mg/ml plus 1.5 
μΐ reservoir) against a 500 μΐ reservoir (100 mM HEPES-
NaOH, pH 7.0, 20% (w/v) PEG-4000, 10% (v/v) 2-propanol). 
The preparation 1 crystals could be improved through trace 
amounts of benzamidine to yield voluminous needles (0.05 
ÄX0.05 ÄX1.0 Ä) which diffracted to about 3.5 Ä resolu-
tion. The initial preparation 2 crystals were larger in all di-
mensions by a factor of 2 and were selected for further refine-
ment. Addition of additives did not have visible effects. Fine 
screening of the PEG-4000/pH combinations, replacing 2-
propanol with MPD, and using hanging drops yielded the 
best crystals so far, which grew in the pH range of 7.0-7.5 
and at PEG-4000 concentrations above 17%. MPD instead of 
2-propanol avoided the formation of additional spherolytic 
crystals and convection currents which were an obstacle in 
mounting. The crystal size and shape was very sensitive to 
the pH with lower values producing a larger number of small, 
perfectly shaped crystals (Fig. 2a) and higher values promot-
ing the formation of fewer, larger crystals with some growth 
defects at the edges (Fig. 2b). 
Preliminary data collection was attempted with the crystals 
mounted in thin-walled capillaries with mother liquor at one 
end. However, the low symmetry space group (PI) required 
data collection over several days, necessitating the search for 
cryogenic buffers. It was found essential to keep the pH in 
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Table 2 
Self rotation function" peaks 
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7.3 crystals clearly survived the shock freezing best. Otherwise 
it sufficed to raise the MPD concentration to about 30%. 
Similar buffer systems should be useful for the collection of 
synchrotron radiation data. With a rotating anode source, the 
crystals diffracted to beyond 2.6 A resolution and yielded a 
complete data set to 2.8 A (Table 1). The space group was 
determined to be triclinic PI (a = 82.2 Ä, b = 84.2 A, c = 116.2 
Ä; a =107.0°, β = 96.3°, γ= 108.0°), suggesting eight eCGS 
monomers per asymmetric unit (VM = 2.23 A3/Da, solvent 
content 32%). The Rmerge was 11.7% for 128009 reflections, 
measured with a 2-fold redundancy, of which 55060 were 
unique above the 3σ level (in F) and were used in the prelimi-
nary crystallographic characterization (Table 1). 
Locked Patterson self rotation functions [21] were calcu-
lated with κ = 90° and κ = 180° (Table 2), screening the asym-
metric unit in 2° intervals. The results clearly indicated the 
presence of two groups of three local orthogonal twofold axes 
(Fig. 3), implying the presence of two eCGS tetramers with 
local 222 symmetry slightly inclined with respect to each oth-
er. 
3.3. Biological significance 
Although the purification of native and recombinant CGS 
from prokaryotic and eukaryotic organisms has been demon-
strated previously [7,12,23,24], we have tailored the prepara-
tion for the first time to the needs of X-ray crystallography, 
demonstrating the reproducible generation of high quality sin-
gle crystals. In terms of product yield and purity as well as 
with respect to its convenience the presented procedures 
match or improve upon previous protocols. 
The Patterson analysis of the current diffraction data 
clearly supports the solution studies indicating that eCGS is 
organized in tetramers. Furthermore, these tetramers should 
exhibit 222 symmetry. Although eCGS is therefore similarly 
structured as eCBL on the quaternary level, and although the 
enzymes share significant sequence homology, the structure 
solution by molecular replacement of the present crystals, 
with eight monomers per asymmetric unit, did not prove to 
be trivial. Currently structure solution strategies via molecular 
and isomorphous replacement are attempted. At the same 
time we are pursuing cocrystallization with inhibitors. 
CGS activities cover a large portion of the spectrum of 
known PLP dependent reactions, with eliminations and/or 
substitutions at the a, β, and γ positions of substrates [3]. 
At the same time CGS is the only enzyme which sponsors a 
physiological substitution at CY of an amino acid. It is there-
fore well suited as a subject to study the mechanisms by which 
substrates are funnelled into either route. Mechanistic details 
ψ 9 0 - 90 ψ 
Fig. 3. Results from a locked self rotation function contoured with a cutoff of 2.5σ. The peaks indicate two groups of three orthogonal axes 
(Table 2). 
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for the reaction mechanism of CGS have been proposed [24— 
26] and recently modified by stopped-flow kinetic measure-
ments [3]. It is hoped that the three-dimensional structure 
will improve our understanding of C G S catalyzed reactions. 
So far the structure of only one member of the structural γ-
family of P L P dependent enzymes, CBL from E. coli [6], has 
been determined. While there exists extensive homology be-
tween the two enzymes they catalyze vastly different reactions 
in vivo. It will be interesting to see how the differential active 
site architectures direct the different chemical scenarios. 
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